In Spain Amgen has a young team of 150 highly qualified professionals

Amgen is a leading-edge company in the use of cellular and molecular biology techniques applied to the development of medicines, and is the world’s largest biotechnology company.

Amgen S.A. was set up in Spain in 1990, with the mission of becoming the largest pharmaceutical company in the country in terms of sales of products derived from biotechnology. From that time until now Amgen, S.A. has made a decisive contribution to the development of clinical research in Spain and has participated directly in the ongoing process to improve therapeutic guidelines and the quality of life of patients.

In Spain Amgen has a young team of 150 highly qualified professionals. Its headquarters are located in the World Trade Center in Barcelona. From day one, the company has slowly increased its influence in the Spanish hospital sector every year.

In addition to numerous and distinguished clinical trials, which are a key contribution made by the Spanish subsidiary of the company to the clinical development of the corporation worldwide, important epidemiology and prevalence studies are also worthy of mention.

Amgen was founded in 1980 in California, the United States. It has a workforce of 17,000 worldwide, is listed on the Nasdaq, and is currently among the ten largest pharmaceutical companies in the world by market capitalization. Amgen invests between 20 and 25% of its total earnings in research, development and innovation.